Biogen Faces Italian Antitrust Probe Over MS Drug Rivalry with Sandoz

Biogen is facing an antitrust probe in Italy concerning its rivalry with Sandoz over multiple sclerosis drugs. The investigation will examine potential anti-competitive practices in the pharmaceutical market.